Leveraging Genetics To Inform Clinical Trials And Drug Development In Alzheimer's Disease
At the Eisai Center for Genetics Guided Dementia Discovery (G2D2), the discovery process starts with human genetics as it aims to better understand...
Source: clinicalleader.com